On Thursday shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) closed at $27.75. Company’s sales growth for last 5 years was -25.00% . On 6 April, Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that data from the Phase 2 EMERGE study of glembatumumab vedotin in metastatic breast cancer have been published in the Journal of Clinical Oncology. The data from this study supported the initiation of the ongoing, pivotal Phase 2 METRIC study in patients with triple negative breast cancers that over-express glycoprotein NMB (gpNMB).
The Coca-Cola Company (NYSE:KO) shares advanced 0.50% in last trading session and ended the day at $40.60. KO Gross Margin is 61.10% and its return on assets is 7.60%. The Coca-Cola Company (NYSE:KO) quarterly performance is -3.81%. The Coca-Cola Company (NYSE:KO) announced that Sandy Douglas, Senior Vice President and President of Coca-Cola North America, will present at 10:45 a.m. EDT, Tuesday, May 12, 2015 during the Goldman Sachs Global Staples Forum being held in New York City.
On last trading day BCE Inc. (NYSE:BCE) fell -0.38% to close at $44.30. Its volatility for the week is 1.05% while volatility for the month is 1.33%. BCE’s sales growth for past 5 years was 3.50% and its EPS growth for past 5 years was 8.80%. BCE Inc. (NYSE:BCE) monthly performance is 5.18%. Scotiabank upgraded shares of BCE Inc. (NYSE:BCE) from a sector perform rating to an outperform rating in a report issued on Monday. They currently have $60.00 target price on the stock, up from their previous target price of $58.00.
Penn Virginia Corporation (NYSE:PVA) has 0.30% insider ownership while its institutional ownership stands at 98.30%. In last trading activity company’s stock closed at $7.43. Penn Virginia Corporation (NYSE:PVA) announced that it will release its first quarter 2015 results after the market closes on Monday, May 11, 2015, and hold a conference call / webcast on Tuesday, May 12, 2015, at 10:00 a.m. ET.